Mr. Andre Jerome reports

AURORA ANNOUNCES DISTRIBUTION PARTNERSHIP BETWEEN MEDRELEAF AUSTRALIA AND THE ENTOURAGE EFFECT

MedReleaf Australia, a wholly owned subsidiary of Aurora Cannabis Inc., has arranged a distribution partnership with The Entourage Effect. The Entourage Effect provides comprehensive distribution and support services to pharmacies in Australia and will serve as a wholesaler for MedReleaf Australia's leading portfolio of products under the CraftPlant, Aurora and IndiMed brands, furthering the mission to expand access for Australian patients.

"We are deeply committed to broadening access to premium medical cannabis for the expanding community of patients who rely on Aurora, and we seek the right partners in the markets in which we operate to make this happen," said Andre Jerome, executive vice-president, global business development, at Aurora. "Our new partnership with The Entourage Effect broadens our already-robust distribution in Australia, ensuring even greater access to our high-quality medical cannabis portfolio, reinforcing our commitment to patient care."

"We are thrilled to be partnering with MedReleaf Australia to facilitate the distribution and wholesaling of their products," said Lisa Varley, chief executive officer of The Entourage Effect. "This collaboration marks a significant milestone for both companies, underscoring our shared commitment to improving patient access and advancing the Australian medicinal cannabis market. Together, we are well positioned to better serve the needs of patients across the nation."

Aurora remains at the forefront of the global medical cannabis industry and is steadfast in supporting the continued growth and development of the rapidly expanding Australian medical cannabis market. MedReleaf Australia, a wholly owned subsidiary of Aurora, is committed to quality and consistency and proudly meets all TGA-GMP (Therapeutic Goods Administration good manufacturing practice) standards.

About Aurora Cannabis Inc.

Aurora is opening the world to cannabis, serving both the medical and consumer markets across Canada, Europe, Australia and South America. Headquartered in Edmonton, Alta., Aurora is a pioneer in global cannabis, dedicated to helping people improve their lives. The company's adult-use brand portfolio includes Drift, San Rafael '71, Daily Special, Tasty's, Being and Greybeard. Medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co. as well as international brands Pedanios, Bidiol, IndiMed and CraftPlant. Aurora also has a controlling interest in Bevo Farms Ltd., North America's leading supplier of propagated agricultural plants. Driven by science and innovation and with a focus on high-quality cannabis products, Aurora's brands continue to break through as industry leaders in the medical, wellness and adult recreational markets wherever they are launched.

Aurora's common shares trade on the Nasdaq Stock Market and the Toronto Stock Exchange under the symbol ACB.

We seek Safe Harbor.